New Therapeutic Options in Congestive Heart Failure: Part I

This publication has 50 references indexed in Scilit:

• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Tachycardia-Related Cardiomyopathy: A Common Cause of Ventricular Dysfunction in Patients With Atrial Fibrillation Referred for Atrioventricular Ablation
  Mayo Clinic Proceedings, 2000
• Vasopressin: A therapeutic target in congestive heart failure?
  Journal of Cardiac Failure, 1999
• Heart failure 99 — the Moxcon story
  International Journal of Cardiology, 1999
• Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
  New England Journal of Medicine, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design)
  The American Journal of Cardiology, 1998
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987